China To Conduct Phase III Trials Of Stem Cell Heart Therapy
This article was originally published in PharmAsia News
Executive Summary
Up to 10 noted public medical institutions in China are expected to participate in Phase III trials of a treatment based on stem cells to treat chronic heart failure.